In healthy volunteers, oral phenylbutyrate 500 mg twice daily with vitamin D3 increased LL‑37 peptide concentration in monocyte-derived macrophages at day 4 versus day 0.
In plain wordsIn healthy volunteers, phenylbutyrate with vitamin D raised the body's own LL‑37 in macrophages after four days, compared with day 0.
- Peptide
- LL-37
- Outcome
- IncreaseLL-37 peptide in macrophages, Group-II, day 4
- Study
n: not reported in source
- Comparator
- Day-0
- Outcome group
- Immune response · Immune and inflammation
Source sentences
MDM from Group-II had increased concentration of LL-37 peptide and transcript at day-4, while Group-I showed increased transcript at day-4 and day-8 compared to day-0 (p < 0.05).
1 context sentence(design, population, supporting numbers)
Healthy volunteers were enrolled in an 8-days open trial with three doses of PB [250 mg (Group-I), 500 mg (Group-II) or 1000 mg (Group-III)] twice daily (b.d.) together with vitamin D3 {5000 IU once daily (o.d.)}, PB (500 mg b.d.) (Group-IV) or vitamin D3 (5000 IU o.d.) (Group-V), given orally for 4 days.
This result measures the body's own LL-37. Nobody was given the peptide. It is not evidence about taking it.